Latest Health News

Aguia Resources has rapidly converted its Pampafós phosphate fertiliser project into commercial sales, securing AUD 600,000 in revenue within 14 days, anchored by a 2,000-tonne contract with a leading Brazilian agricultural cooperative.

Meteoric Resources has secured key federal endorsements for its Caldeira Rare Earth Project’s environmental licensing, keeping the Installation License on schedule for December 2026 and paving the way for a final investment decision.

RLF AgTech has revamped its executive remuneration to tie CEO incentives directly to share price hurdles, revenue growth, and operating cash flow, reinforcing its focus on sustainable profitability.

Neurizon Therapeutics has secured a critical five-year supply agreement with Elanco Animal Health for GMP-grade monepantel, underpinning the commercialisation readiness of its lead ALS drug candidate NUZ-001.

Island Pharmaceuticals has won a key regulatory boost as the US FDA granted Orphan Drug Designation to Galidesivir for post-exposure prophylaxis of Marburg virus disease, enhancing its commercial and development prospects.

Island Pharmaceuticals has presented encouraging Phase 2a results for its dengue antiviral ISLA-101, demonstrating safety, effective blood concentrations, and meaningful viral load reductions at the Asia Dengue Summit.

HomeCo Daily Needs REIT has recorded a $92 million gross valuation increase driven by net operating income growth, maintaining strong operational metrics and reaffirming its FY26 distribution and FFO guidance.

InteliCare (ASX:ICR) is hitting a commercial inflection point, backed by a landmark $8.8 million contract with mecwacare and a growing pipeline across aged care sectors. Its AI-powered platform promises measurable improvements in care outcomes and operational efficiency.

Charter Hall Social Infrastructure REIT (CQE) has acquired a 25% interest in a $53 million Brisbane pathology lab leased to Sonic Healthcare under a 20-year triple-net lease, while divesting early learning assets and reaffirming FY26 guidance.

Benjamin Hornigold Limited's shares were suspended from trading on 15 June 2026 after the company failed to lodge its required periodic report by the ASX deadline.

Evolution Energy Minerals (ASX:EV1) is set to launch its maiden drilling campaign at Tanzania's Chikundo Copper Project, targeting multiple high-confidence copper anomalies defined by recent soil sampling and historical data.

TruScreen has secured clinical validation from the world’s largest cervical screening study in China, setting the stage for rapid market expansion across Asia, Africa, and Europe.